85006-1754 ALYMSYS - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

85006-1754

Brand Name:

ALYMSYS

Generic Name:

Bevacizumab-maly

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: BEVACIZUMAB-MALY

Strength: 100.0

Unit: mg/4mL

Packages:

Code: 85006-1754-01

Description: 1 VIAL in 1 CARTON (85006-1754-1) / 4 mL in 1 VIAL

Effective Date: April 15, 2022

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

VEGF

Orphan Drug Designation:

Status:

In Use